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1. Introduction 
In United States, the prevalence of obesity has increased from 11.9% to 33.4% in men and 
from 16.6% to 36.5% in women from 1971 to 2006 (Austin, Spadano-Gasbarro et al. 2011). In 
general, obesity is caused by energy imbalance where energy intake exceeds energy 
expenditure for an extended period of time. The excess energy is stored in adipose tissue 
and results in enlarged fat cells and/or increased number of fat cells. Obesity is of great 
concern because a subset of the population has co-morbidities that develop as a consequence 
of obesity. Previous studies have shown that obesity is one of the risk factors linked to 
metabolic syndrome (Bray 2004). The World Health Organization (WHO) defines metabolic 
syndrome as a cluster of disorders that require the presence of diabetes, impaired glucose 
tolerance (IGT), impaired fasting glucose or insulin resistance and any two of the following 
abnormalities: central obesity, dyslipidemia (high triglycerides or low high-density 
lipoprotein (HDL) cholesterol concentration), elevated blood pressure, or micro albuminuria 
(Alberti and Zimmet 1998).  
Type 2 diabetes mellitus (T2DM) is well known to be a metabolic disease that is 
characterized by insulin resistance and impaired insulin secretion. Insulin resistance is a 
condition in which the peripheral tissues, such as muscle and adipose tissue, lose the ability 
to uptake plasma glucose efficiently at physiological concentrations of insulin. As a result, 
the pancreas secretes more insulin to compensate. Therefore, insulin resistance leads to high 
plasma concentrations of insulin and glucose, and results in T2DM. Moreover, 
hyperglycemia causes cardiovascular diseases and disease-specific complications such as 
blindness and kidney failure (Zimmet, Alberti et al. 2001). The increased prevalence of 
T2DM is strongly associated with obesity (Mokdad, Ford et al. 2003) and is becoming an 
increasing problem worldwide (King, Abdullaev et al. 1998; Cowie, Rust et al. 2006; Yoon, 
Lee et al. 2006). In just the United States, 23.6 million people over the age of 20 have 
diabetes, of which 90% to 95% have T2DM (Cowie, Rust et al. 2006). An overwhelming 
25.9% of the US population over 20 years old has early stages of disease by exhibiting 
impaired fasting glucose levels (Cowie, Rust et al. 2006). Additionally, The International 
Diabetes Federation predicted that 333 million people will have diabetes by 2025 (King 1998; 
King, Abdullaev et al. 1998; King, Aubert et al. 1998). Therefore, it is very important to 
determine the causes of this disease and develop strategies for its prevention. 
The correlation between obesity and the prevalence of T2DM has been well established, but 
how does T2DM develop? In 1963, Randle et al proposed that lipids impaired insulin-
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stimulated glucose uptake in muscle and was caused by inhibition of glycolysis (Randle 
1963). Excess circulating free fatty acids (FFA) in obesity is one of the main factors that 
contribute to development of T2DM (Randle 1963; Randle 1998). Because FFA are elevated 
in the blood of obese individuals, the muscle has access to more FFA compared to lean 
individuals and thus obese individuals have increased fatty acid oxidation in their muscles 
(Boden 1997). This in turn, results in an increased generation of metabolites from FFA ┚-
oxidation such as, nicotinamide adenine dinucleotide (NADH), acetyl-CoA and adenosine 
triphosphate (ATP). These metabolites inhibit key regulatory enzymes in the glycolytic 
pathway such as pyruvate dehydrogenase complex (PDC). The increased concentration of 
ATP also inhibits phosphofructokinase (PFK-1) and pyruvate kinase muscle isoform (PK-
M), thus blocking the rate controlling steps in muscle glycolysis and subsequently leads to 
an accumulation of glucose-6-phosphate (G6P). Increased concentration of G6P inhibit 
hexokinase and therefore decreases the rate of glucose phosphorylation by muscle which 
increases the blood glucose concentration (Randle 1963). Randle et al also found that FFA 
oxidation blocks the recycling of the glucose transporter 4 (GLUT4) to the surface of muscle 
cells, thus decreasing glucose uptake and contributes to the increased blood glucose levels 
(Randle 1963). In summary, the elevated FFA have been demonstrated to lead to insulin 
resistance in peripheral tissues by inhibiting insulin-stimulated glucose uptake in the muscle 
causing elevated blood glucose (Boden 1997). 
2. Triglyceride/fatty acid cycle and glyceroneogenesis 
What regulates the flux of FFA between tissues? The triglyceride/fatty acid cycle regulates 
this flux. In the fed state glucose is metabolized to glycerol-3-phosphate via glycolysis and 
esterifies with three FFA to generate triglycerides (Figure 1). This occurs in both the liver 
and white adipose tissues (WAT). FFA are derived both from either the diet or de novo 
lipogenesis in the liver. FFA generate energy via ┚-oxidation as described above in various 
tissues (muscle, heart) or can be stored as triglycerides in adipose tissue for energy 
production at a later time. 
During fasting however as much as 65% of FFA are re-esterified back to triglycerides in 
WAT (Jensen, Chandramouli et al. 2001). Since glucose is at a premium during fasting, the 
synthesis of glycerol-3-phosphate from glucose is minimal. Additionally, in WAT the 
glycerol released during lipolysis cannot be phosphorylated and used for triglyceride 
synthesis because the activity of glycerol kinase in this tissue is negligible. Reshef, Ballard 
and Hanson demonstrated that gluconeogenic precursors such as pyruvate and lactate are 
converted into glycerol backbone of triglyceride (Reshef, Hanson et al. 1970; Reshef, 
Meyuhas et al. 1972). This pathway called “glyceroneogenesis” is an abbreviated version of 
gluconeogenesis. Glyceroneogenesis is defined as the conversion of precursors other than 
glucose or glycerol into glycerol 3-phosphate for triglyceride synthesis. The pathway is 
essential for the regulation of the FFA flux between tissues during fasting (Botion, Kettelhut 
et al. 1995; Botion, Brito et al. 1998; Festuccia, Kawashita et al. 2003).  
Glyceroneogenesis, like gluconeogenesis, is regulated by phosphoenolpyruvate 
carboxykinase (PEPCK-C/Pck1), a key enzyme which catalyzes the conversion of 
oxaloacetate (OAA) to phosphoenolpyruvate (PEP) in both pathways. During fasting, 
increasing hepatic Pck1 expression enhances the rates of gluconeogenesis to maintain 
glucose homeostasis as well as glyceroneogenesis, thus increasing hepatic glucose output 
and triglycerides synthesis by re-esterification of circulating FFA (Fig. 1). In adipose tissue, 
glyceroneogenesis controlled by Pck1 contributes to the regulation of FFA release to the 
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blood. Support for Pck1 regulation of glyceroneogenesis contributing to the development of 
disease was shown by Franckhauser et al. They over-expressed of Pck1 in WAT through a 
transgene specific for adipose tissue and found increased FFA re-esterification in adipose 
tissue led to obesity without insulin resistance (Franckhauser, Antras-Ferry et al. 1995; 
Franckhauser, Munoz et al. 2002). The increased glyceroneogenesis reduced the availability 
of FFA to the muscle and thus prevented impaired glucose tolerance. Therefore the 
regulation of triglyceride/FFA cycle is important in the development of obesity and T2DM. 
Figure 1. Triglyceride/FFA cycle regulates the flux of lipids between tissues. 
 
 
Fig. 1. Triglyceride-fatty acid cycle. During fasting triglycerides are hydrolyzed to glycerol 
and FFA. However as much as 65% of FFA are re-esterfied back to triglycerides. Pck1 
regulates this process in both adipose tissue and liver.  
In order to investigate the disturbance of triglyceride/fatty acid cycle in development of 
obesity and T2DM, various genetic alterations of the Pck1 gene have been conducted. Mice 
with a whole body null mutation of Pck1 do not survive beyond 3 days after birth (She, 
Shiota et al. 2000). Therefore, the PPARE-/- mice were generated to circumvent this problem. 
The binding site for the peroxisome proliferator-activated receptor ┛ (PPAR┛), called the 
peroxisome proliferator-activated receptor element (PPARE), at -1000 bp of the Pck1 
promoter is essential for adipose tissue expression (Devine, Eubank et al. 1999). The deletion 
of PPARE region in Pck1 promoter in mice (PPARE-/-) led to dramatic loss of Pck1 
expression in WAT and mammary gland, and slight reduction in BAT (Hsieh, Millward et 
al. 2009). Loss of Pck1 expression in the adipose tissue resulted in reduced adipocyte size 
and fat content (Olswang, Cohen et al. 2002) due to impaired glyceroneogenesis in adipose 
tissue. Further research found PPARE-/- mice displayed insulin resistance and altered lipid 
and glucose homeostasis (Millward, DeSantis et al. 2010). Thus the alteration of the 
triglyceride/FFA cycle can lead to development of impaired glucose tolerance. 
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Further evidence for the role of Pck1 in the regulation of the triglyceride/FFA cycle has been 
shown in genomic analysis in humans. Beale et al have established that two C/T single 
nucleotide polymorphisms (SNPs) were in complete linkage disequilibrium at position –
1097bp and –967bp of the Pck1 promoter and these SNPs are associated with obesity and 
T2DM. Patients with T/T polymorphisms have higher HbA1c and higher fasting glucose 
levels (Beale, Harvey et al. 2007). The region of the identified polymorphisms in these 
patients is located within the same PPARE site of Pck1 promoter that has been deleted in 
PPARE-/- mice (Millward, Desantis et al. 2010). These mice lack Pck1 expression in WAT and 
develop insulin resistance with elevated plasma FFA (Millward, DeSantis et al 2010). 
In mice that had altered triglyceride/FFA cycle via loss of Pck1 in mammary gland and 
WAT, the dams’ had 40% reduction of milk triglycerides during lactation. The pups reared 
by these dams had reduced growth in the perinatal period and developed insulin resistance 
that persisted into adulthood (Hsieh, Millward et al. 2009). Thus understanding the 
regulation of lipid metabolism during pregnancy and lactation may provide new insights 
into the mechanism(s) for development of T2DM. 
3. The thrifty hypothesis 
How does the alteration of perinatal nutrition program the fetus for T2DM? One theory for the 
interaction of environment in development of disease is “the thrifty phenotype hypothesis”. 
The thrifty phenotype hypothesis suggested that the metabolic adaption during early life 
altered “thrifty genes” expression to help people survive when food sources were limited; 
however, those genes predispose us to diabetes and became detrimental in our modern 
lifestyle with an abundance of food (Neel 1962). The theory associates poor fetal growth with 
increased risk for a number of chronic conditions, including diabetes, hypertension, 
dyslipidemia, coronary artery disease and stroke, in adulthood (Barker 2004; Fernandez-
Twinn and Ozanne 2006). Suboptimal nutrition during pregnancy is one of the significant 
problems that causes infants to suffer from intrauterine growth retardation (IUGR) (Marsal 
2002). IUGR has been strongly associated with the development of metabolic disorders, 
hormone imbalance, organ dysfunction and abnormal development, as well as cardiovascular 
disorders (Wu, Bazer et al. 2004). Malnutrition and overnutrition during pregnancy as well as 
alterations in placental function all contribute the development of IUGR and further 
“program” the fetus to development of a variety of chronic diseases (Wu, Bazer et al. 2004). 
The “programming” hypothesis suggests that maternal malnutrition can induce permanent 
changes in the fetal genome through DNA methylation, histone acetylation, or other 
modifications on transcriptional or translational levels (Meaney and Szyf 2005) and contribute 
to development of metabolic diseases in the future. Therefore, low birth weight (LBW) is 
regarded as an independent risk factor for development of T2DM and other adult-onset 
diseases in adulthood (Hernandez-Valencia and Patti 2006). 
4. Animal models for studying programming of the metabolic syndrome 
during pregnancy/lactation 
Several nutritional models have been used to illustrate the mechanism that would explain 
fetal origins for adult diseases. We summarized some of these models for studying 
programming of the newborns (Table 1). To investigate the impact of maternal overnutrtion 
on the fetus, several studies have used the high-fat diet during pregnancy /lactation. They 
have shown that exposure to the high fat diet during pregnancy results in altered 
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metabolism in the newborn can also lead to the development of metabolic diseases, 
including insulin resistance and dysfunction of pancreatic ┚-cells, in the offspring (Elton, 
Pennington et al. 2002; Buckley, Keseru et al. 2005; Taylor, McConnell et al. 2005). Thus, 
maternal nutrition directly impacts the developing ┚-islet cells and can program the fetus 
for insulin resistance as adults. 
 
 
Table 1. Imprinting the fetus for T2DM 
To investigate the impact of undernutrition on programming the fetus for adult diseases, 
two different dietary strategies are commonly used, global nutritional restriction and 
isocaloric low protein manipulation. In rodents, total maternal restriction of 50% of caloric 
needs in the last week of pregnancy results in impairment of ┚-cell development (Garofano, 
Czernichow et al. 1997). If calorie restriction continues during suckling, permanent 
reduction in ┚-cell mass and ┚-cell number occurs resulting in impaired glucose tolerance 
(Garofano, Czernichow et al. 1998). If rodent dams are more severely restricted to 30% of 
total caloric intake, the fetus develops systolic hypertension, increased fasting insulin 
concentrations, increased food intake and obesity (Vickers, Breier et al. 2000). Limiting a 
single macronutrient in the dams also imprints the fetus. When maternal protein intake 
during pregnancy is reduced to 8%, the offspring have low birth weight (LBW), reduced ┚-
cell islet size (Snoeck, Remacle et al. 1990) and reduced ┚- islets insulin content and secretion 
(Dahri, Snoeck et al. 1991). Peripheral tissues are also affected in the pups from dams fed 
low protein diet. When the pups were adults (15 months old), insulin stimulated glucose 
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uptake in skeletal and adipose tissues is reduced (Ozanne, Dorling et al. 2001; Ozanne, 
Olsen et al. 2003). Small birth weight can also be due to impaired nutrient perfusion through 
the placenta (Haggarty, Allstaff et al. 2002). To mimic placental insufficiency in rodents, 
unilateral and bilateral uterine artery ligations have been used. These studies established 
that the fetus develop reduced ┚-cell mass which persists into adulthood (Wigglesworth 
1974; De Prins and Van Assche 1982).  
5. Alterations in fetal nutrition 
LBW in newborns is a reduction in both lean body mass and fat mass. After birth, these 
infants have accelerated postnatal growth or catch-up growth (CUG) (Eriksson, Forsen et al. 
1999; Bhargava, Sachdev et al. 2004). Several studies have suggested that the fat mass 
accrues preferentially during CUG and the fat accumulation during childhood is a 
significant risk factor for T2DM as adults (Crescenzo, Samec et al. 2003; Rasmussen, Malis et 
al. 2005; Ibanez, Ong et al. 2006; Leunissen, Oosterbeek et al. 2008). Several strategies have 
been employed to test the consequences of overnutrition on programming the fetus for adult 
disease. These include reduction of litter size during lactation, high fat diet during 
pregnancy. Reduction of litter size from 14 to 4 rat pups per litter results in 
hyperinsulinemia, increased body growth and obesity as adults (Plagemann, Heidrich et al. 
1992). Rats fed a high fat diet (20% kcal fat) during pregnancy and lactation had significantly 
higher milk lipid, protein and lactose concentration compared to the low fat diet group 
(5%kcal fat). The weights of the pups from the high fat mothers is similar at birth but 
increases after 6 days and persists into adulthood (Del Prado, Delgado et al. 1997).  
During the suckling period, milk lipids provide the major source of both calories and 
essential fatty acids for the rodent newborn. The neonate uses fatty acids and ketone bodies 
as their primary energy substrate during lactation and must switch to carbohydrate after 
weaning (Grigor, Allan et al. 1986; Rolls, Gurr et al. 1986; Del Prado, Delgado et al. 1997; Del 
Prado, Villalpando et al. 1999). ). Patel et al have extensively studied the patterning effect of 
overnutrtion in the perinatal period by high-carbohydrate feeding during the suckling 
period (Aalinkeel, Srinivasan et al. 1999; Aalinkeel, Srinivasan et al. 2001; Patel and 
Srinivasan 2002). They used an artificial rearing technique where newborn rats were raised 
in styrofoam cups floating in a temperature-controlled water bath called “pup-in-a-cup”. At 
day 4 postpartum, the rats were fed through intragastric cannulas a high carbohydrate 
formula where 56% of the total calories is carbohydrate compared to 8% normally found in 
rodent milk. The pups develop hyperinsulinemia within 24 hours which persists into 
adulthood. Patel et al have investigated both cellular and molecular adaptations in response 
to the patterning of high carbohydrate diet and insulin secretion. The pancreas has profound 
changes. The pancreas from the high carbohydrate fed animals has increased number of 
smaller sized ┚-islets with an increase of immunopositive staining area for insulin. The islets 
also has reduced apoptosis (Petrik, Srinivasan et al. 2001). The molecular changes include 
increases in expression of transcription factors regulating the expression of the 
preproinsulin mRNA.  
Undernutrition during lactation can also impact the fetus. A study using female rats showed 
that exposure to dietary conjugated linoleic acids resulted in decreased triglyceride 
concentration in the milk via reduced de novo fatty acid synthesis in the mammary gland 
and an impaired uptake of fatty acids from lipoprotein into mammary gland (Ringseis, Saal 
et al. 2004). The lower triglyceride concentration of milk led to impaired fetal growth and 
www.intechopen.com
 
Role of Triglyceride/Fatty Acid Cycle in Development of Type 2 Diabetes 
 
59 
increased mortality of the suckling pups. As we discussed earlier, alterations in the 
triglyceride/FFA cycle also reduce triglyceride concentration of milk and lead to 
programming the fetus to develop insulin resistance (Hsieh, Millward et al 2009). Thus 
understanding the regulation of lipid metabolism during pregnancy and lactation may 
provide new insights into the mechanism(s) for development of insulin resistance.  
6. Transgenerational programming of fetus 
The data described above suggests epigenetic patterning of the fetus for disease due to 
either genetic or environmental conditions. However there is little evidence for 
transgenerational effects of the environment in mammals. Most examples of 
transgenerational environmental effects described in the literature are maternal effects. In 
Table 2 we have summarized these studies. Aalinkeel et al analyzed pups that were fed a 
high carbohydrate diet instead of the normal high lipid diet during the first three weeks of 
life. These pups develop insulin resistance and become obese (Aalinkeel, Srinivasan et al 
1999). The F1 generation from these mice also develop obesity and insulin resistance even 
though the F1 generation had no dietary alterations (Aalinkeel, Srinivasan et al 2001; Patel, 
Srinivasan 2002). In another study C57BL/6J dams (F0) were fed high fat diet during 
pregnancy. The pups develop obesity and metabolic syndrome that is transmitted through 
to the F3 generation (Dunn, Bail et al 2011). Another study showed that caloric restriction of 
the dam during pregnancy (F0) results in reduced birth weight, impaired glucose tolerance 
and obesity (Jimenez-Chillaron, Isganaitis et al 2009). The environmental imprinting caused 
by F0 dam also imprints not only the F1 generation but also the F2 generation (Jimenez-
Chillaron, Isganaitis et al 2009). Thus, the original environmental insult to the grandmother 
or mother imprints not only the fetus but future generations as well.  
Recent evidence indicates that it is not just the mother that can imprint the fetus for 
development of disease. Several studies showed that environmental insults to the 
grandfather or father imprint the fetus for several generations as well (Table 2). In congenic 
strains derived from an obesity susceptible strain, C57BL/6J and a resistant strain, A/J, 
identified a region that protects the fetus from diet-induced obesity on high fat diet. This 
small region of the A/J chromosome, Obrq2aA/J, in an otherwise C57BL/6J background 
shows that the paternal or grandpaternal allele is sufficient to inhibit diet-induced obesity 
and reduce food intake in the normally obesity-susceptible C57BL/6J strain (Yazbek, Spiezio 
et al 2010). In another study when the male C57BL/6J mouse (M) was fed a low-protein diet 
and then mated to C57BL/6J female mouse (F), the progeny has increased hepatic gene 
expression for genes in the lipogenic pathway (Carone, Fauquier et al 2010). Finally, when 
obese male Sprague-Dawley rats were mated to females fed a low-fat diet the F1 generation 
developed altered ┚-cell function (Ng, Lin et al 2010). Therefore, environmental insults to 
the grandfather and father can also imprint the fetus for development of obesity and insulin 
resistance.  
7. Conclusion 
The development of obesity and insulin resistance is a complex disease since it is 
mutlifactorial and both genetics as well as the environment contribute to the development of 
T2DM. Environmental stresses to either parent can result in imprinting of the fetus for 
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T2DM. Future studies will define the mechanism(s) responsible for imprinting the fetus for 
disease and offer new therapeutic strategies for prevention of T2DM. 
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